Results 131 to 140 of about 16,901 (224)

Mapping the antibody response to Lassa virus vaccination of non-human primates. [PDF]

EBioMedicine
Enriquez AS, Avalos RD, Parekh D, Cooper CL, Morrow G, Geisbert TW, Parks CL, Hastie KM, Saphire EO.   +8 more
europepmc   +1 more source

Serological Evidence of Lassa Virus Exposure in Non-<i>Mastomys</i> Small Mammals Within a Hyperendemic Region of North-Central Nigeria: A Pilot Study. [PDF]

Viruses
Edegbene AO, Omotehinwa TO, Anejo-Okopi J, Yaagoubi SE, Shittu OS, Audu O, Abah EO, Ijoganu S, Kwaghgande G, Aju-Ameh C, Abimbola A, Otache E, Ameh E, Danyi J, Ikwu O, Cegbeyi EAM, Agboola OO, Okoeguale J, Eifediyi RA, Agbo EB, Idoko JA, Ujah IOA, Abah SO.   +22 more
europepmc   +1 more source

Safety, tolerability, and immunogenicity of INO-4500, a synthetic DNA-based vaccine against Lassa virus, in a phase 1b clinical trial in healthy Ghanaian adults. [PDF]

Front Immunol
Koram KA, Walker KA, Orizu B, Marrero I, Boyer J, Yang S, Broderick KE, Kusi KA, Kyei-Baafour E, Ofori EA, Pobee A, Adu-Amankwah S, Amoakoh-Coleman M, Amoakoh HB, Abuaku B, Badji E, Ntiri M, Quaye L, Morrow MP, Sylvester AJ, Reuschel EL, Gillespie E, Liebowitz D, Humeau LM.   +23 more
europepmc   +1 more source

The systematic use of cost-effectiveness criteria to inform decisions about the removal of items from publicly-financed 'benefits packages'. A report commissioned by the Department of Health and prepared by the London School of Hygiene and Tropical Medicine [PDF]

, 2007
Ettelt, S, Mays, N, Nolte, E, Thomson, S
core  

Detection of Immunoglobulin G and/or IgM antibodies specific for Lassa virus among HIV patients in the Northwestern region of Cameroon. [PDF]

Virol J
Abongwa LE, Njefi K, Ngum NH, Rogeson T, Ahmed M, Ajayi OI, Djoufack GD, Eromon P, Ugwu C, Folarin O, Happi C.   +10 more
europepmc   +1 more source

Expansion of myeloid suppressor cells and suppression of Lassa virus-specific T cells during fatal Lassa fever. [PDF]

PLoS Pathog
Lafoux B, Fourcaud G, Hortion J, Soyer L, Journeaux A, Germain C, Reynard S, Cousseau H, Larignon C, Pietrosemoli N, Croze S, Lachuer J, Perthame E, Baize S.   +13 more
europepmc   +1 more source

Clinical characterization of host response to simian hemorrhagic fever virus infection in permissive and refractory hosts: A model for determining mechanisms of VHF pathogenesis [PDF]

, 2019
Bailey, Adam L, et al,
core   +1 more source

The Lassa Virus Stable Signal Peptide Undergoes a Conformational Change to Aid Viral Fusion. [PDF]

Chemistry
Collins SD, Jiang L, Liu Y, Lee J.
europepmc   +1 more source

Coadministration of ribavirin and arenaviral entry inhibitor LHF-535 enhances antiviral benefit against authentic lassa virus. [PDF]

Virol Sin
Peng C, Hu J, Bai Y, Wu W, Mao W, Liu Y, Wan Y, Zhang L, Li W, Tian T, Liu T, Wang Y, Liang M, Han J, Yuan Z, Li J, Shan C, Deng F, Wang W.   +18 more
europepmc   +1 more source

Africa [PDF]

, 2008

core